Whitefort Capital Management, LP
Follow13F filer, CIK 1884931, NEW YORK, NY
Whitefort Capital Management, LP reported $338,335,124 across 18 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14. Its ten largest share positions make up 89.44% of the portfolio.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001013594-25-001427
- Period
- 2025-09-30
- Reported value
- $338M
- Holdings
- 18
- Top 10 weight
- 89.44%
- New
- 3
- Sold out
- 3
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| BALYnew | +1,343,243 | $14.9M |
| IWMnew | +33,000 | $7.98M |
| OABIadded | +3,983,512 | $6.37M |
| OPKadded | +3,125,800 | $4.84M |
| GNWadded | +480,000 | $4.27M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| JOYYreduced | -509,999 | -$29.9M |
| LQDAreduced | -724,193 | -$16.5M |
| GSLexited | -353,857 | -$9.31M |
| ROIVreduced | -350,000 | -$5.3M |
| TRIBexited | -81,902 | -$53.2K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2025
Share positions as resolved from 13F-HR 0001013594-25-001427, largest first. % of portfolio is the value over $302,090,235, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| ABUSARBUTUS BIOPHARMA CORP | 13,343,228 | $60.6M | 20.05% | 0 | Timeline | ||
| ROIVROIVANT SCIENCES LTD | 3,532,000 | $53.4M | 17.69% | -350,000 | Timeline | ||
| GNWGENWORTH FINL INC | 3,701,960 | $32.9M | 10.91% | +480,000 | Timeline | ||
| JOYYJOYY INC | 404,944 | $23.7M | 7.86% | -509,999 | Timeline | ||
| OABIOMNIAB INC | 14,223,658 | $22.8M | 7.53% | +3,983,512 | Timeline | ||
| CDZICADIZ INC | 3,986,822 | $18.8M | 6.23% | 0 | Timeline | ||
| BALYBALLYS CORPORATION | 1,343,243 | $14.9M | 4.94% | new | Timeline | ||
| TDAYUSA TODAY CO INC | 3,585,406 | $14.8M | 4.9% | +913,485 | Timeline | ||
| LQDALIQUIDIA CORPORATION | 607,409 | $13.8M | 4.57% | -724,193 | Timeline | ||
| SGRYSURGERY PARTNERS INC | 371,000 | $8.03M | 2.66% | 0 | Timeline | ||
| IWMISHARES TR | 33,000 | $7.98M | 2.64% | new | Timeline | ||
| OPKOPKO HEALTH INC | 4,900,000 | $7.59M | 2.51% | +3,125,800 | Timeline | ||
| KGKESTREL GROUP LTD | 160,916 | $4.39M | 1.45% | +58,710 | Timeline | ||
| VATEINNOVATE CORP | 743,000 | $3.63M | 1.2% | 0 | Timeline | ||
| NNAVWNEXTNAV INC | 47,264 | $256K | 0.08% | 0 | Timeline |
Options
Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).
Principal amounts
Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).
| Security | Type | Amount | Value | Change |
|---|---|---|---|---|
| OPKO HEALTH INCOPKO HEALTH INC NOTE 3.750% 1/1 | principal | 9,350,000 | $14.4M | 0 |
Sold out in Q3 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| GSLGLOBAL SHIP LEASE INC | 353,857 | $9.31M | shares |
| INNOVATE CORPINNOVATE CORP | 12,218,000 | $6.34M | principal |
| TRIBTRINITY BIOTECH INVT LTD | 81,902 | $53.2K | shares |
How Q3 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001013594-25-001427 | base | 2025-11-14 | acceptance time not in the bulk data set |